Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
18.97
-0.37 (-1.91%)
Mar 9, 2026, 3:00 PM EDT - Market open
Amphastar Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 861 | 1,231 | 1,785 | 2,963 | 1,354 | 1,114 | Upgrade
|
| Market Cap Growth | -42.81% | -31.07% | -39.75% | 118.80% | 21.52% | 16.65% | Upgrade
|
| Enterprise Value | 1,229 | 1,611 | 2,165 | 3,336 | 1,273 | 1,106 | Upgrade
|
| Last Close Price | 19.34 | 26.78 | 37.13 | 61.85 | 28.02 | 23.29 | Upgrade
|
| PE Ratio | 9.36 | 12.55 | 11.19 | 21.54 | 14.82 | 17.94 | Upgrade
|
| Forward PE | 5.74 | 7.78 | 9.42 | 20.77 | 16.29 | 16.96 | Upgrade
|
| PS Ratio | 1.19 | 1.71 | 2.44 | 4.60 | 2.71 | 2.55 | Upgrade
|
| PB Ratio | 1.12 | 1.56 | 2.44 | 4.63 | 2.56 | 2.50 | Upgrade
|
| P/TBV Ratio | 3.84 | 5.52 | 12.60 | 113.42 | 2.76 | 2.74 | Upgrade
|
| P/FCF Ratio | 7.06 | 10.15 | 10.36 | 20.39 | 20.79 | 15.80 | Upgrade
|
| P/OCF Ratio | 5.48 | 7.88 | 8.37 | 16.15 | 15.19 | 11.37 | Upgrade
|
| PEG Ratio | 1.38 | 7.01 | 0.99 | 0.92 | 0.86 | 0.89 | Upgrade
|
| EV/Sales Ratio | 1.71 | 2.24 | 2.96 | 5.18 | 2.55 | 2.53 | Upgrade
|
| EV/EBITDA Ratio | 5.58 | 7.32 | 8.38 | 14.03 | 9.63 | 11.65 | Upgrade
|
| EV/EBIT Ratio | 7.52 | 9.85 | 10.54 | 16.70 | 11.85 | 15.43 | Upgrade
|
| EV/FCF Ratio | 10.14 | 13.29 | 12.56 | 22.95 | 19.55 | 15.68 | Upgrade
|
| Debt / Equity Ratio | 0.83 | 0.83 | 0.89 | 0.98 | 0.19 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 2.85 | 2.85 | 2.46 | 2.56 | 0.75 | 1.05 | Upgrade
|
| Debt / FCF Ratio | 5.41 | 5.41 | 3.78 | 4.29 | 1.58 | 1.48 | Upgrade
|
| Net Debt / Equity Ratio | 0.47 | 0.47 | 0.59 | 0.57 | -0.14 | -0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.70 | 1.70 | 1.66 | 1.54 | -0.55 | -0.34 | Upgrade
|
| Net Debt / FCF Ratio | 3.08 | 3.08 | 2.49 | 2.52 | -1.12 | -0.45 | Upgrade
|
| Asset Turnover | 0.45 | 0.45 | 0.47 | 0.57 | 0.71 | 0.67 | Upgrade
|
| Inventory Turnover | 2.20 | 2.20 | 2.76 | 2.78 | 2.55 | 2.51 | Upgrade
|
| Quick Ratio | 2.80 | 2.80 | 2.07 | 1.65 | 2.79 | 2.08 | Upgrade
|
| Current Ratio | 4.02 | 4.02 | 3.07 | 2.17 | 3.99 | 3.06 | Upgrade
|
| Return on Equity (ROE) | 12.90% | 12.90% | 23.26% | 23.55% | 18.76% | 14.16% | Upgrade
|
| Return on Assets (ROA) | 6.37% | 6.37% | 8.31% | 11.07% | 9.51% | 6.88% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.19% | 11.17% | 15.98% | 22.19% | 19.68% | 13.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.10% | 11.10% | 14.60% | 15.50% | 16.60% | 12.60% | Upgrade
|
| Earnings Yield | 11.46% | 7.97% | 8.94% | 4.64% | 6.75% | 5.57% | Upgrade
|
| FCF Yield | 14.16% | 9.85% | 9.65% | 4.91% | 4.81% | 6.33% | Upgrade
|
| Buyback Yield / Dilution | 7.38% | 7.38% | 1.78% | -1.09% | -5.31% | -1.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.